Glasgow, Scotland, November 10, 2021 – Embraer (NYSE: ERJ) incubator Eve Urban Air Mobility Solutions, Inc. (Eve), an Embraer company, and Wideroe Zero signed a Memorandum of Understanding (MoU). This partnership aims to develop Urban Air Mobility (UAM) solutions, with a focus on deployment of eVtol operations in Scandinavia.
The relationship between the two organizations began in 2017, when Wideroe signed an order for up to 15 E190-E2. The largest regional airline in Scandinavia is also the launch customer of the new generation E-Jets E2 family, starting the E190-E2 operations in April 2018 in Bergen, Norway.
Now, with the creation of the Air Mobility Business Incubator, Wideroe Zero, the companies will use Eve’s zero-emission and low noise footprint eVTOL vehicle to develop a new concept of operation where passengers will experience the future of electric transportation and a new model of sustainable mobility, connecting people living in a sparsely populated region and challenging geography.
As part of this collaboration, Wideroe Zero will contribute to a market readiness exercise and a vehicle concept of operation study in Scandinavia, furthering Eve’s development of the UAM market in the region.
Embraer today announced the Phenom 300MED, a unique Medevac solution for Phenom 300 series aircraft, which is also available for retrofit, through a partnership with umlaut and Aerolite. Embraer and umlaut are jointly developing and certifying a new supplemental type certificate (STC) utilizing Aerolite equipment.
The Phenom 300MED, which is now available for customer configuration, is representative of Embraer’s modern and versatile product portfolio and the company’s intent to deliver the ultimate experience in business aviation, now including the Medevac segment. Designed as an ideal solution for both civil and government applications, the Medevac solution will be installed exclusively by Embraer’s award-winning Services & Support organization, ensuring the highest quality, reliability, and service experience, direct from the manufacturer.
Together, Embraer and umlaut are developing a comprehensive set of configuration alternatives for the Phenom 300MED, which will feature either one or two stretchers, as well as the ability to carry an incubator and additional medical equipment. The aircraft will also feature hospital-grade trim and finishing. As a purpose-built Medevac solution, created in collaboration with the leading companies in the industry, the Phenom 300MED is designed to be quickly and easily configured to meet the various needs of both healthcare providers and patients.
The Phenom 300MED benefits from the platform’s heritage of best-in-class cabin pressurization, low operating costs, high mission flexibility, state-of-the-art avionics, plus its speed and range capabilities. With best-in-class cabin altitude of 6,600 feet, passengers and crew enjoy more oxygen in the cabin. This feature equates to a healthier flight experience, which is essential for medical staff and patient care.
The Phenom 300MED is further distinguished by the integration of Aerolite medical equipment. Aerolite is a leader in the design, engineering, production, and installation of Air Medical interiors. With over 500 Medevac interiors delivered, the company offers the ideal blend of equipment for the mission.
Ronald Hengartner, CEO of Aerolite, said, “We are honored that Embraer and umlaut have selected Aerolite’s innovative aeromedical equipment for the new Phenom 300MED. From providing the most modern EMS interior solutions to offering customer-specific support and training, Aerolite is uniquely positioned to help deliver the ultimate Medevac solution.”
Embraer’s products, including the Phenom 300 series, are recognized for high reliability and utilization. More than 550 Phenom 300 series aircraft have been delivered since the aircraft entered the market in December 2009, and it has accumulated more than one million flight hours. According to VREF’s 15-year business aircraft residual value forecast, the Phenom 300E will retain one of the highest residual values in the industry.
